Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QIPT
10501
CALL
DELISTED
Quipt Home Medical
QIPT
| $154K | ﹤0.01% |
22,000
+16,500
| +300% | +$102K |
|
10502
Celcuity
CELC
$4.5B
| $154K | ﹤0.01% |
15,043
-889
| -6% | -$9.74K |
|
10503
CALL
Eagle Bancorp
EGBN
$872M
| $154K | ﹤0.01% |
4,600
-4,100
| -47% | -$175K |
|
10504
CALL
Consumer Portfolio Services
CPSS
$202M
| $154K | ﹤0.01% |
14,400
-11,400
| -44% | -$116K |
|
|
IMMP
10505
Immutep
IMMP
$56.8M
| $154K | ﹤0.01% |
91,626
+72,116
| +370% | +$133K |
|
10506
Airgain
AIRG
$72.3M
| $154K | ﹤0.01% |
28,664
+9,817
| +52% | +$68.3K |
|
10507
PUT
Prospect Capital
PSEC
$1.12B
| $154K | ﹤0.01% |
22,100
-33,400
| -60% | -$243K |
|
10508
PUT
ImmunityBio
IBRX
$8.36B
| $154K | ﹤0.01% |
84,500
+6,000
| +8% | +$18.7K |
|
10509
PUT
CVRx
CVRX
$76.7M
| $154K | ﹤0.01% |
16,500
+13,800
| +511% | +$183K |
|
10510
PUT
Invesco China Technology ETF
CQQQ
$3.23B
| $154K | ﹤0.01% |
3,300
-5,600
| -63% | -$260K |
|
10511
CALL
Dr. Reddy's Laboratories
RDY
$10.1B
| $154K | ﹤0.01% |
13,500
+9,000
| +200% | +$97.1K |
|
10512
CALL
Pulse Biosciences
PLSE
$3.3B
| $154K | ﹤0.01% |
45,700
+25,100
| +122% | +$75.7K |
|
10513
Amplitude
AMPL
$1.57B
| $153K | ﹤0.01% |
12,337
-50,941
| -81% | -$676K |
|
10514
PUT
Provident Financial Services
PFS
$3.22B
| $153K | ﹤0.01% |
8,000
-2,800
| -26% | -$61.9K |
|
10515
PUT
Recursion Pharmaceuticals
RXRX
$1.68B
| $153K | ﹤0.01% |
23,000
+21,700
| +1,669% | +$172K |
|
|
CANG
10516
Cango Inc
CANG
$73.4M
| $153K | ﹤0.01% |
13,455
+11,958
| +799% | +$158K |
|
|
MAPS
10517
CALL
DELISTED
WM TECHNOLOGY INC A
MAPS
| $153K | ﹤0.01% |
180,600
-61,800
| -25% | -$66.4K |
|
10518
PUT
iShares S&P 500 Growth ETF
IVW
$77.8B
| $153K | ﹤0.01% |
2,400
-9,800
| -80% | -$599K |
|
10519
CALL
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$42B
| $153K | ﹤0.01% |
3,400
-15,600
| -82% | -$668K |
|
10520
PUT
SGHC Ltd
SGHC
$6.63B
| $153K | ﹤0.01% |
38,000
+28,000
| +280% | +$101K |
|
10521
CALL
Zumiez
ZUMZ
$306M
| $153K | ﹤0.01% |
8,300
+3,500
| +73% | +$80.5K |
|
10522
PUT
DT Midstream
DTM
$13.8B
| $153K | ﹤0.01% |
3,100
+2,500
| +417% | +$130K |
|
10523
PUT
Coca-Cola Femsa
KOF
$22.8B
| $153K | ﹤0.01% |
1,900
-2,300
| -55% | -$169K |
|
10524
PUT
FormFactor
FORM
$10.8B
| $153K | ﹤0.01% |
4,800
+3,200
| +200% | +$91.7K |
|
|
MSSAU
10525
DELISTED
Metal Sky Star Acquisition Corporation Unit
MSSAU
| $153K | ﹤0.01% |
+13,581
| New | +$149K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.